The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $53.35

Today's change+1.18 +2.25%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
 

AmSurg Corp

Nasdaq: AMSG
Last

(U.S.) $53.35

Today's change+1.18 +2.25%
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.

AmSurg Corp Hits New 20-day High

AmSurg Corp closed up sharply Friday, rallying (U.S.)$1.18 or 2.25% to (U.S.)$53.35 and setting a new 20-day high. Over the last five days, shares have gained 8.63% and are currently 2.07% off of the 52-week high. Shares have outperformed the S&P 500 by 2.47% during the last year.

Key company metrics

  • Open(U.S.) $52.28
  • Previous close(U.S.) $52.18
  • High(U.S.) $53.93
  • Low(U.S.) $52.28
  • Bid / Ask-- / --
  • YTD % change+16.18%
  • Volume1,268,799
  • Average volume (10-day)536,848
  • Average volume (1-month)510,013
  • Average volume (3-month)433,626
  • 52-week range(U.S.) $40.00 to (U.S.) $54.48
  • Beta1.10
  • Trailing P/E43.15×
  • P/E 1 year forward20.23×
  • Forward PEG0.90×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.24
Updated December 19 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue503281263283
Total other revenue--------
Total revenue503281263283
Gross profit461240224241
Total cost of revenue42413942
Total operating expense408193183195
Selling / general / administrative266858386
Research & development--------
Depreciation / amortization21988
Interest expense (income), net operating--------
Unusual expense (income)0-1-20
Other operating expenses, total82605559
Operating income95888089
Interest income (expense), net non-operating-39-7-7-7
Gain (loss) on sale of assets--------
Other--------
Income before tax39817381
Income after tax39686068
Income tax, total0131313
Net income-10191720
Total adjustments to net income-2------
Net income before extra. items-8191819
Minority interest-47-49-43-49
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10191819
Inc. avail. to common incl. extra. items-12191720
Diluted net income-12191720
Dilution adjustment000--
Diluted weighted average shares46323232
Diluted EPS excluding extraordinary itemsvalue per share-0.220.590.540.60
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.220.550.490.60